For research use only. Not for therapeutic Use.
LY 137150(CAT: I007756) is a potent and selective thromboxane A2 (TXA2) receptor antagonist, widely utilized in cardiovascular and hematological research. By inhibiting TXA2-mediated platelet aggregation and vasoconstriction, LY 137150 provides valuable insights into thrombotic disorders, atherosclerosis, and vascular dysfunction. This compound is instrumental in exploring the role of TXA2 signaling in pathological conditions and aids in the development of novel antithrombotic and cardiovascular therapies. Its high specificity and efficacy make LY 137150 an essential tool for preclinical studies targeting thromboxane receptor pathways.
Catalog Number | I007756 |
CAS Number | 86315-69-7 |
Synonyms | LY 137150; LY137150; LY-137150.;1H-Imidazo(4,5-c)pyridine, 2-(2-methoxy-4-(methylthio)phenyl)-, monohydrochloride |
Molecular Formula | C14H14ClN3OS |
Purity | ≥95% |
Solubility | Soluble in DMSO |
Storage | 0 - 4°C for short term , or -20°C for long term. |
IUPAC Name | 2-(2-methoxy-4-methylsulfanylphenyl)-3H-imidazo[4,5-c]pyridine;hydrochloride |
InChI | InChI=1S/C14H13N3OS.ClH/c1-18-13-7-9(19-2)3-4-10(13)14-16-11-5-6-15-8-12(11)17-14;/h3-8H,1-2H3,(H,16,17);1H |
InChIKey | LMAGMIYNWNPGLS-UHFFFAOYSA-N |
SMILES | COC1=C(C=CC(=C1)SC)C2=NC3=C(N2)C=NC=C3.Cl |